Clinical Oncology Next-generation Sequencing Market Forecast & SWOT Analysis - PowerPoint PPT Presentation

About This Presentation
Title:

Clinical Oncology Next-generation Sequencing Market Forecast & SWOT Analysis

Description:

Clinical Oncology Next-generation Sequencing Market: Launch of Low-cost Sequencing Platforms to Accelerate Adoption: Global Industry Analysis 2014-2018 and Opportunity Assessment 2019-2029 – PowerPoint PPT presentation

Number of Views:105
Slides: 9
Provided by: Umesh213
Category: Other

less

Transcript and Presenter's Notes

Title: Clinical Oncology Next-generation Sequencing Market Forecast & SWOT Analysis


1

Clinical Oncology Next-generation Sequencing
Market 2021 Statistical Analysis, Key Segments,
Benefits and Opportunity and Forecast, 2029 FMI
  • May 2021

Report Id   REP-GB-9543 Published On  
2019-05-17Category Healthcare, Pharmaceuticals
Medical Devices
2
AboutFuture Market Insights
Future Market Insights (FMI) is a premier
provider of syndicated research reports, custom
research reports, and consulting services. We
deliver a complete packaged solution, which
combines current market intelligence, statistical
anecdotes, technology inputs, valuable growth
insights, aerial view of the competitive
framework, and future market trends. We provide
research services at a global as well as regional
level key regions include GCC, ASEAN,
and BRIC. Our offerings cover a broad spectrum of
industries including Chemicals, Materials,
Energy, Technology, Healthcare, and Retail. We
have a global presence with delivery centers
across India specializing in providing global
research reports and country research reports.
FMI is headquartered out of London, U.K., with a
state-of-the-art delivery center located in Pune,
India. We combine our knowledge and learning from
every corner of the world to distill it to one
thing the perfect solution for our client.
Research Capabilities
Sector Coverage
  • Customized Research
  • Syndicated Research
  • Investment Research
  • Social Media Research

  • Automotive and Transportation
  • Electronics, Semiconductor, and ICT
  • Retail and Consumer Products
  • Industrial Automation and Equipment
  • Chemicals Materials
  • Food and Beverages
  • Services and Utilities
  • Energy, Mining, Oil, and Gas

Subscription Information

For detailed subscription information please
contact Hari. T (Sr. Manager - Global Business
Development) T 44 (0) 20 7692 8790 D 44
20 3287 4268 Email hari.t_at_futuremarketinsights.co
m
3
Research Methodology (1/2)
  • Systematic Research Approach

In-depth secondary research is used to ascertain overall market size, top industry players, top products, industry associations, etc.
FMI formulates a detailed discussion guide to conduct expert and industry interviews
FMI develops a list of industry players (manufacturers), distributors, retailers and industry experts
FMI conducts interviews with industry experts, industry players, distributors and retailers
Data is validated by triangulation method, wherein secondary, primary and FMI analysis contribute to the final data
Data is scrutinized using MS-Excel to obtain qualitative and quantitative insights about the industry
FMI delivers industry insights and information in the required format (PDF)
  • Identifying key opinion leaders
  • Questionnaire design
  • In-depth interviews
  • Coverage across value chain
  • Key industry experts
  • Channel study
  • Developments
  • Market dynamics
  • Products
  • Conclusions

SOLUTION
  • Market participants
  • Key strengths
  • Product portfolio
  • Mapping as per value chain
  • Key focus segments

Primary Research
Secondary Research
Paid Publications
  • Linkedin
  • Zoominfo
  • Salesforce
  • Avention
  • Factiva
  • GBI
  • Genios
  • Meltwater
  • Company websites
  • Company annual reports
  • White papers
  • Financial reports

includes sources of databases
4
Clinical Oncology Next-generation Sequencing
Market Analysis
Next-generation sequencing refers to the
identification of the nucleotides of DNA base
pairs for the diagnosis of various diseases.
Oncology is one of the important applications
of next-generation sequencing. It is an advanced
and faster method of sequencing. Clinical
oncology next-generation sequencing includes kits
reagents, services, sequencing platforms, and
sequencing products. The kits and reagents used
for sequencing are expected to witness
significant growth in the overall market. North
America is expected to be a prominent region in
the global clinical oncology next-generation
sequencing market due to well-developed
healthcare infrastructure and numerous
technological advancements in the region. North
America and Europe are expected to witness a
significant growth rate in the clinical oncology
next-generation sequencing market. Request a
Sample Report with Table of Contents and
Figures https//www.futuremarketinsights.com/repo
rts/sample/rep-gb-9543 Synthesis Sequencing
Technology to Hold a Major Market Value
Share Based on the technology, the clinical
oncology next-generation sequencing market has
been segmented into pyro sequencing, sequencing
by synthesis (SBS), and Single-Molecule Real-Time
Sequencing (SMRT), nanopore sequencing, ligation
sequencing, and reversible dye termination
sequencing.
5
Clinical Oncology Next-generation Sequencing
Market Analysis
Synthesis sequencing is however expected to hold
a significant share in the clinical oncology
next-generation sequencing market. Ion
semiconductor sequencing is a method of DNA
sequencing in which hydrogen ions are detected
based on the polymerisation of DNA.
Pyro-sequencing includes identifying the order of
nucleotides in DNA based on the "sequencing by
synthesis" principle, in which the sequencing is
performed with the help of DNA polymerase. SBS is
a technique used to determine the series of base
pairs in DNA, also known as DNA
sequencing. Clinical Oncology Next-generation
Sequencing Market Launch of Low-cost Sequencing
Platforms to Accelerate Adoption Global Industry
Analysis 2014-2018 and Opportunity Assessment
2019-2029  https//www.futuremarketinsights.com/r
eports/clinical-oncology-next-generation-sequencin
g-market There are various applications
associated with clinical oncology next-generation
treatment market. They include whole tumor genome
sequencing, whole tumour exome sequencing,
targeted tumour genome profiling, tumour
transcriptome sequencing, tumour-normal
comparisons, and other applications. Targeted
tumor genome profiling is expected to hold a
large share of the clinical oncology
next-generation treatment market. The clinical
oncology next-generation sequencing market has
been segmented into hospital laboratories,
clinical research organisations, diagnostic
laboratories, and others based on end user.
Clinical research laboratories are expected to
hold a large revenue share in the clinical
oncology next-generation sequencing market.
6
Clinical Oncology Next-generation Sequencing
Market Analysis
Apart from the factors driving the clinical
oncology next-generation sequencing market, few
factors are likely to hinder the overall growth
of the clinical oncology next-generation
sequencing market, such as high costs associated
with the establishment of sequencing platforms,
low quality of outsourcing services, and
inadequate availability of sequencing platforms
in some regional markets. On the other hand,
increasing biomedical research using clinical
oncology, increasing government funding for life
science projects, substantial decline in the
prices of sequencing, and technological
advancements in the field of sequencing are some
of the major factors driving the growth of the
clinical oncology next-generation sequencing
market. Tier 1 Companies Hold Nearly 3/5th Share
of Global Market Value The report tracks some of
the key companies operating in the clinical
oncology next-generation sequencing market such
as QIAGEN N.V., Thermo Fisher Scientific.,
Pacific Biosciences of California, Inc., F.
Hoffmann-La Roche Ltd Oxford Nanopore
Technologies, Ltd., Takara Bio, Inc., Illumina
Inc., PerkinElmer Inc.and Agilent Technologies,
Inc. Thermo Fischer Scientific, Oxford Nanopore
Technologies Ltd., and Illumina are expected to
hold a signficant share of the clinical oncology
next-generation sequencing market. These first
tier companies hold a share of approximately 60
in the clinical oncology next-generation
sequencing market.
7
Clinical Oncology Next-generation Sequencing
Market Analysis
  • More from FMIs Healthcare, Pharmaceuticals and
    Medical devices Market Intelligence
  • Viscosupplementation Industry Opportunity
    Analysis - Global Industry Analysis, Size, Share,
    Growth, Trends and Forecast 2019 to 2029
  • Opioid Induced Respiratory Depression Market
    Analysis - Global Industry Analysis, Size, Share,
    Growth, Trends and Forecast 2019 2029
  • High Resolution Anoscopy Market Analysis - Global
    Industry Analysis, Size, Share, Growth, Trends
    and Forecast 2019 - 2029

8
To know more about us, please visit our website
www.futuremarketinsights.com For sales queries
or new topics email us on sales_at_futuremarketinsi
ghts.com For media queries, contact the press
office at press_at_futuremarketinsights.com For
other queries contactHari. T (Sr. Manager -
Global Business Development) Future Market
Insights 3rd Floor,207 Regent Street, London
W1B 3HH T 44 20 7692 8790 D 44 20 3287
4268 Email hari.t_at_futuremarketinsights.com
Thank You
Future Market Insights Global Consulting
Private Limited (FMI)
Write a Comment
User Comments (0)
About PowerShow.com